Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.
J Thorac Cardiovasc Surg. 2011 Feb;141(2):322-7. doi: 10.1016/j.jtcvs.2010.10.043.
Thoracic endovascular aortic repair for chronic type B aortic dissection with associated descending thoracic aneurysm remains controversial. Concerns include potential ischemic complications due to branch vessel origin from the chronic false lumen and continued retrograde false lumen/aneurysm sac pressurization via fenestrations distal to implanted endografts. The present study examines midterm results with thoracic endovascular aortic repair for chronic (>2 weeks) type B aortic dissection with associated aneurysm to better understand the potential role of thoracic endovascular aortic repair for this condition.
Between March 2005 and December 2009, 51 thoracic endovascular aortic repair procedures were performed at a single institution for management of chronic type B dissection. The indication for thoracic endovascular aortic repair was aneurysm in all cases. A subset of 7 patients (14%) underwent placement of the EndoSure wireless pressure measurement system (CardioMEMS, Inc, Atlanta, Ga) in the false lumen adjacent to the primary tear for monitoring aneurysm sac/false lumen pulse pressure after thoracic endovascular aortic repair.
Mean patient age was 57±12 years (range, 30-82 years); 14 patients (28%) were female. Mean aortic diameter was 6.2±1.4 cm. There were no in-hospital/30-day deaths, strokes, or permanent paraplegia/paresis. There were no complications related to compromise of downstream branch vessels arising from the false lumen. Two patients (3.9%) who had preexisting ascending aortic dilation had retrograde acute type A aortic dissection; both were repaired successfully. Median postoperative length of stay was 4 days. Mean follow-up is 27.0±16.5 months (range, 2-60 months). Actuarial overall survival is 77.7% at 60 months with an actuarial aorta-specific survival of 98% over this same time period. Actuarial freedom from reintervention is 77.3% at 60 months. All patients with the EndoSure wireless pressure measurement system exhibited a decrease in aneurysm sac/false lumen pulse pressure indicating a depressurized false lumen. The aneurysm sac/false lumen pulse pressure ratio decreased from 52%±27% at the predischarge measurement to 14%±5% at the latest follow-up reading (P=.029).
Thoracic endovascular aortic repair for chronic type B dissection with associated aneurysm is safe and effective at midterm follow-up. Aneurysm sac/false lumen pulse pressure measurements demonstrate a significant reduction in false lumen endotension, thus ruling out clinically significant persistent retrograde false lumen perfusion and provide proof of concept for a thoracic endovascular aortic repair-based approach. Longer-term follow-up is needed to determine the durability of thoracic endovascular aortic repair for this aortic pathology.
胸主动脉腔内修复术治疗慢性 B 型主动脉夹层合并降主动脉瘤仍存在争议。人们关注的问题包括分支血管起源于慢性假腔以及通过植入的血管内移植物远端的开窗导致逆行假腔/瘤囊持续加压可能引起的缺血性并发症。本研究旨在通过对慢性(>2 周)B 型主动脉夹层合并动脉瘤患者行胸主动脉腔内修复术的中期结果,更好地了解胸主动脉腔内修复术在这种情况下的潜在作用。
2005 年 3 月至 2009 年 12 月,在一家医疗机构对 51 例慢性 B 型主动脉夹层患者行胸主动脉腔内修复术。所有患者的适应证均为动脉瘤。7 例患者(14%)接受了 EndoSure 无线压力测量系统(CardioMEMS,Inc,亚特兰大,佐治亚州)的植入,该系统被植入到原发性撕裂口附近的假腔中,以监测胸主动脉腔内修复术后瘤囊/假腔脉搏压力。
患者平均年龄为 57±12 岁(范围 30-82 岁);14 例(28%)为女性。主动脉直径平均为 6.2±1.4cm。院内/30 天无死亡、卒中和永久性截瘫/轻偏瘫。无与假腔起源的下游分支血管受压相关的并发症。2 例(3.9%)原有升主动脉扩张的患者发生逆行性急性 A 型主动脉夹层,均成功修复。术后中位住院时间为 4 天。平均随访时间为 27.0±16.5 个月(范围 2-60 个月)。60 个月时的总生存率为 77.7%,同一时期的主动脉特异性生存率为 98%。60 个月时免于再次干预的生存率为 77.3%。所有植入 EndoSure 无线压力测量系统的患者的瘤囊/假腔脉搏压力均降低,表明假腔减压。在出院时的测量中,瘤囊/假腔脉搏压比为 52%±27%,在最近的随访读数中为 14%±5%(P=.029)。
慢性 B 型主动脉夹层合并动脉瘤患者行胸主动脉腔内修复术在中期随访时是安全有效的。瘤囊/假腔脉搏压力测量结果显示假腔内张力显著降低,从而排除了临床上显著的逆行假腔灌注,并为基于胸主动脉腔内修复术的治疗方法提供了概念验证。需要更长时间的随访来确定胸主动脉腔内修复术在这种主动脉病变中的耐久性。